EUVIMEDEUVIMED entdecken
Open Access

Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models

Amer El Ghali iD, Kyle Stamper, Ashlan J Kunz Coyne iD, Dana Holger iD, Razieh Kebriaei, Jose Alexander, Susan M Lehman iD, Michael J Rybak iD

Antimicrobial Agents and Chemotherapy · 15.11.2023 · 67 (11)

DOI: 10.1128/aac.00728-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 15.11.2023. Verfasst von Amer El Ghali und 7 weiteren Autor:innen. Beteiligte Einrichtung: Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences , Detroit, Michigan, US…. Hauptthemen laut MEDLINE: Bacteriophages, Pseudomonas Infections. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pseudomonas aeruginosa -associated infective endocarditis represents difficult-to-treat, deep-seated infections. Phage-antibiotic combinations have shown to eradicate multi-drug resistant (MDR) P. aeruginosa , limit the development of phage resistance, and restore antibiotic sensitivity. The objective of this study was to evaluate the activity of phage-ciprofloxacin (CIP) combinations in 4-day ex vivo simulated endocardial vegetation (SEV) models against drug-resistant P. aeruginosa isolates. Two P. aeruginosa isolates, extensively drug-resistant AR351 and MDR I0003-1, were selected for their drug resistance and sensitivity to phage. Three phages [LL-5504721-AH (LL), E2005-C (EC), and 109] and CIP were evaluated alone and in combination for their activity and influence on drug and phage resistance using 24-h time-kill analysis. The three-phage cocktail (q24h) in combination with CIP (400 mg q12h) was then tested in dynamic 4-day ex vivo SEV models, with reduction of log 10 CFU/mL compared using ANOVA with Bonferroni analysis. Compared to other combinations, CIP-LL-EC-109 demonstrated synergistic and bactericidal activity from starting CFU/g against AR351 and I0003-1 (−Δ5.65 and 6.60 log 10 CFU/g, respectively; P < 0.001). Additionally, CIP-LL-EC-109 mitigated phage resistance, while all other therapies had a high degree of resistance to >1 phages, and all phage-containing regimens prevented CIP mean inhibitory concentration increases compared to CIP alone for both AR351 and I0003-1 at 96 h.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriophagesPseudomonas InfectionsHumansCiprofloxacinPseudomonas aeruginosaAnti-Bacterial Agents

Stichwörter der Autor:innen

Pseudomonas aeruginosabacteriophagesex vivo simulated endocardial vegetation modelsinfective endocarditismulti-drug resistancephage resistancephage therapyphage-antibiotic combinations

Substanzen

CiprofloxacinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences , Detroit, Michigan, USA.
  • Department of Microbiology, Virology and Immunology, AdventHealth Central Florida , Orlando, Florida, USA.
  • Center for Biologics Evaluation and Research, U.S. Food and Drug Administration , Silver Spring, Maryland, USA.
  • Department of Medicine, Division of Infectious Diseases, Wayne State University , Detroit, Michigan, USA.

ORCID-Profile: Amer El Ghali, Ashlan J Kunz Coyne, Dana Holger, Susan M Lehman, Michael J Rybak

Zitieren

APA

El Ghali, A., Stamper, K., Kunz Coyne, A. J., Holger, D., Kebriaei, R., Alexander, J., Lehman, S. M., & Rybak, M. J. (2023). Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models. Antimicrobial Agents and Chemotherapy, 67(11). https://doi.org/10.1128/aac.00728-23

Vancouver

El Ghali A, Stamper K, Kunz Coyne AJ, Holger D, Kebriaei R, Alexander J, et al. Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models. Antimicrobial Agents and Chemotherapy. 2023;67(11). doi:10.1128/aac.00728-23

BibTeX
@article{ElGhali2023,
  author = {El Ghali, Amer and Stamper, Kyle and Kunz Coyne, Ashlan J and Holger, Dana and Kebriaei, Razieh and Alexander, Jose and Lehman, Susan M and Rybak, Michael J},
  title = {Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  volume = {67},
  number = {11},
  doi = {10.1128/aac.00728-23}
}
Kostenlos starten →